WonderBiotics Probiotics for Weight Management
Named strains, transparent labeling, and ingredient-level human research
WonderBiotics lists Bifidobacterium animalis subsp. lactis B420 among its named strains. The most relevant study here is a six-month randomized, placebo-controlled trial that assigned 225 adults to four groups: placebo, polydextrose, B420 alone, or B420 with polydextrose. The studied B420 dose was 10 billion CFU per day. The intention-to-treat and per-protocol analyses did not yield identical conclusions; in particular, the primary body-fat outcome was not significant in the intention-to-treat analysis. This was a study of B420 and polydextrose, not a trial of the finished WonderBiotics formula. Read the original trial and its limitations.
How the B420 ingredient trial was designed
225
adults randomized across four study groups
4 arms
placebo, fiber, B420, and B420 plus fiber
6 months
placebo-controlled trial duration
209
included in the intention-to-treat analysis
Stenman LK et al., EBioMedicine 2016;13:190-200. B420 ingredient study, not a trial of this finished product.
The formula also lists named strains including B. lactis HN019, L. acidophilus NCFM, and L. rhamnosus GG. WonderBiotics' ingredient-level research tally reports 624 clinical studies and 44,692 human subjects across the ingredient panel. These are aggregated ingredient-level figures, not studies or participants in a trial of this finished formula; the underlying study registry and participant deduplication have not been independently verified here. Research on an individual strain is relevant context, but studies of different strains and populations are not a clinical trial of this combined formula.
The earlier 5X absorption shorthand refers to separate dihydroberberine research, not the absorption or weight-management effect of this product. In a five-person crossover pilot, 100 mg dihydroberberine produced approximately 6.7 times the two-hour plasma berberine exposure of 500 mg berberine under the study conditions. The pilot did not find a short-term difference in glucose or insulin and did not test this finished formula. Read the human pilot study.
Editorial scorecard
Why WonderBiotics Is My Top Pick
My editorial preference here is for the named-strain label and the ability to inspect published ingredient research. The B420 study is relevant context, with the analysis limits described above; it is not proof that this finished formula changes waist size, appetite, blood sugar, or medication-related symptoms.
I serve on WonderBiotics' Scientific Advisory Board under a contractual relationship. Readers should weigh that relationship alongside the linked original research and the current product label.
Explore the WonderBiotics formula, full ingredient label, and current purchase terms.
See the product page for current pricing, subscription and refund terms.
